Story · Medicine & Biotech · Fitness
Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial
1 outlet · first reported by MedPage Today on
(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested... (MedPage Today)
Coverage, in order
-
Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested...
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.